Skip Navigation
Skip to contents

JMD : Journal of Movement Disorders

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse Articles > Author index
Search
Sun Ha Paek 4 Articles
Long-Term Outcomes of Deep Brain Stimulation in Pantothenate Kinase-Associated Neurodegeneration-Related Dystonia
Kyung Ah Woo, Han-Joon Kim, Seung-Ho Jeon, Hye Ran Park, Kye Won Park, Seung Hyun Lee, Sun Ju Chung, Jong-Hee Chae, Sun Ha Paek, Beomseok Jeon
J Mov Disord. 2022;15(3):241-248.   Published online July 26, 2022
DOI: https://doi.org/10.14802/jmd.22002
  • 2,590 View
  • 166 Download
  • 2 Web of Science
  • 2 Crossref
AbstractAbstract PDFSupplementary Material
Objective
To investigate the long-term clinical outcomes of pallidal deep brain stimulation (GPi-DBS) in patients with pantothenate kinase-associated neurodegeneration (PKAN).
Methods
We reviewed the records of patients with genetically confirmed PKAN who received bilateral GPi-DBS for refractory dystonia and were clinically followed up for at least 2 years postoperatively at two centers in Korea. Pre- and postoperative Burke– Fahn–Marsden Dystonia Rating Scale motor subscale (BFMDRS-M) scores, disability subscale (BFMDRS-D) scores, and qualitative clinical information were prospectively collected. Descriptive analysis was performed for BFMDRS-M scores, BFMDRSD scores, and the orofacial, axial, and limb subscores of the BFMDRS-M at 6–12, 24–36, and 60–72 months postoperatively.
Results
Five classic-type, four atypical-type, and one unknown-type PKAN cases were identified. The mean preoperative BFMDRS-M score was 92.1 for the classic type and 38.5 for the atypical or unknown type, with a mean BFMDRS follow-up of 50.7 months and a clinical follow-up of 69.0 months. The mean improvements in BFMDRS-M score were 11.3%, 41.3%, and 30.5% at 6–12, 24–36, and 60–72 months, respectively. In four patients with full regular evaluations until 60–72 months, improvements in the orofacial, axial, and limb subscores persisted, but the disability scores worsened from 24–36 months post-operation compared to the baseline, mainly owing to the aggravation of eating and feeding disabilities.
Conclusion
The benefits of GPi-DBS on dystonia may persist for more than 5 years in PKAN. The effects on patients’ subjective disability may have a shorter duration despite improvements in dystonia owing to the complex manifestations of PKAN.

Citations

Citations to this article as recorded by  
  • Deep Brain Stimulation for Refractory Status Dystonicus in Children: Multicenter Case Series and Systematic Review
    Lindsey M. Vogt, Han Yan, Brendan Santyr, Sara Breitbart, Melanie Anderson, Jürgen Germann, Karlo J. Lizarraga, Angela L. Hewitt, Alfonso Fasano, George M. Ibrahim, Carolina Gorodetsky
    Annals of Neurology.2024; 95(1): 156.     CrossRef
  • Surgical treatment of movement disorders in neurometabolic conditions
    Alonso Zea Vera, Andrea L. Gropman
    Frontiers in Neurology.2023;[Epub]     CrossRef
Development of Clinical Milestones in Parkinson’s Disease After Bilateral Subthalamic Deep Brain Stimulation
Jed Noel A. Ong, Jung Hwan Shin, Seungho Jeon, Chan Young Lee, Han-Joon Kim, Sun Ha Paek, Beomseok Jeon
J Mov Disord. 2022;15(2):124-131.   Published online May 26, 2022
DOI: https://doi.org/10.14802/jmd.21106
  • 2,187 View
  • 131 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract PDFSupplementary Material
Objective
Deep brain stimulation of the subthalamic nucleus (STN-DBS) in Parkinson’s disease (PD) patients does not halt disease progression, as these patients will progress and develop disabling non-levodopa responsive symptoms. These features may act as milestones that represent the overall functionality of patients after DBS. The objective of this study was to investigate the development of clinical milestones in advanced PD patients who underwent bilateral STN-DBS.
Methods
The study evaluated PD patients who underwent STN-DBS at baseline up to their last follow-up using the Unified Parkinson’s Disease Rating Scale and Hoehn and Yahr scale. The symptoms of hallucinations, dysarthria, dysphagia, frequent falls, difficulty walking, cognitive impairment and the loss of autonomy were chosen as the clinical milestones.
Results
A total of 106 patients with a mean age of 47.21 ± 10.52 years at disease onset, a mean age of 58.72 ± 8.74 years at surgery and a mean disease duration of 11.51 ± 4.4 years before surgery were included. Initial improvement of motor symptoms was seen after the surgery with the appearance of clinical milestones over time. Using the moderately disabling criteria, 81 patients (76.41%) developed at least one clinical milestone, while 48 patients (45.28%) developed a milestone when using the severely disabling criteria.
Conclusion
STN-DBS has a limited effect on axial and nonmotor symptoms of the PD patients, in contrast to the effect on motor symptoms. These symptoms may serve as clinical milestones that can convey the status of PD patients and its impact on the patients and their caregivers. Therefore, advanced PD patients, even those treated with bilateral STN-DBS, will still require assistance and cannot live independently in the long run.

Citations

Citations to this article as recorded by  
  • Unveiling the Impact of Outpatient Physiotherapy on Specific Motor Symptoms in Parkinson’s Disease: A Prospective Cohort Study
    Yuta Terasawa, Koki Ikuno, Shintaro Fujii, Yuki Nishi, Emi Tanizawa, Sachio Nabeshima, Yohei Okada
    Brain & Neurorehabilitation.2023;[Epub]     CrossRef
Successful Pallidal Deep Brain Stimulation in a Patient with Childhood-Onset Generalized Dystonia with ANO3 Mutation
Dallah Yoo, Han-Joon Kim, Jong-Hee Chae, Sun Ha Paek, Beomseok Jeon
J Mov Disord. 2019;12(3):190-191.   Published online July 17, 2019
DOI: https://doi.org/10.14802/jmd.19016
  • 5,144 View
  • 120 Download
  • 8 Web of Science
  • 8 Crossref
PDFSupplementary Material

Citations

Citations to this article as recorded by  
  • The Clinical Spectrum of ANO3—Report of a New Family and Literature Review
    Marco Percetti, Michela Zini, Paola Soliveri, Filippo Cogiamanian, Mariarosa Ferrara, Eva Orunesu, Alessandra Ranghetti, Carlo Ferrarese, Gianni Pezzoli, Barbara Garavaglia, Ioannis Ugo Isaias, Giorgio Sacilotto
    Movement Disorders Clinical Practice.2024;[Epub]     CrossRef
  • A novel ANO3 variant in two siblings with different phenotypes
    Marcello Esposito, Assunta Trinchillo, Francesca Piceci-Sparascio, Maria Cecilia D'Asdia, Federica Consoli, Alessandro De Luca
    Parkinsonism & Related Disorders.2023; 111: 105413.     CrossRef
  • DBS-Evoked Pallidal Activity Correlates with Clinical Improvement in a Patient with ANO3-Related Dystonia
    Aditya Boddu, Adam Bashir, Mohammad Awad, Barton Guthrie, Harrison Walker
    SSRN Electronic Journal.2023;[Epub]     CrossRef
  • Deep Brain Stimulation in Dystonia: Disentangling Heterogeneity
    Alberto Albanese
    Movement Disorders Clinical Practice.2021; 8(1): 6.     CrossRef
  • Pallidal Deep Brain Stimulation for Monogenic Dystonia: The Effect of Gene on Outcome
    Stephen Tisch, Kishore Raj Kumar
    Frontiers in Neurology.2021;[Epub]     CrossRef
  • The expanding clinical and genetic spectrum of ANO3 dystonia
    Li-Ting Jiang, Li-Xi Li, Ying Liu, Xiao-Long Zhang, You-Gui Pan, Lin Wang, Xin-Hua Wan, Ling-Jing Jin
    Neuroscience Letters.2021; 746: 135590.     CrossRef
  • Huntington disease-like phenotype in a patient with ANO3 mutation
    Shahedah Koya Kutty, Eoin Mulroy, Francesca Magrinelli, Giulia Di Lazzaro, Anna Latorre, Kailash P. Bhatia
    Parkinsonism & Related Disorders.2021; 90: 120.     CrossRef
  • Arching deep brain stimulation in dystonia types
    Han-Joon Kim, Beomseok Jeon
    Journal of Neural Transmission.2021; 128(4): 539.     CrossRef
Nonmotor Symptoms and Subthalamic Deep Brain Stimulation in Parkinson’s Disease
Han-Joon Kim, Beom S. Jeon, Sun Ha Paek
J Mov Disord. 2015;8(2):83-91.   Published online May 31, 2015
DOI: https://doi.org/10.14802/jmd.15010
  • 24,330 View
  • 244 Download
  • 52 Web of Science
  • 44 Crossref
AbstractAbstract PDF
Subthalamic deep brain stimulation (STN DBS) is an established treatment for the motor symptoms in patients with advanced Parkinson’s disease (PD). In addition to improvements in motor symptoms, many studies have reported changes in various nonmotor symptoms (NMSs) after STN DBS in patients with PD. Psychiatric symptoms, including depression, apathy, anxiety, and impulsivity, can worsen or improve depending on the electrical stimulation parameters, the locations of the stimulating contacts within the STN, and changes in medications after surgery. Global cognitive function is not affected by STN DBS, and there is no increase in the incidence of dementia after STN DBS compared to that after medical treatment, although clinically insignificant declines in verbal fluency have been consistently reported. Pain, especially PD-related pain, improves with STN DBS. Evidence regarding the effects of STN DBS on autonomic symptoms and sleep-related problems is limited and remains conflicting. Many symptoms of nonmotor fluctuations, which are occasionally more troublesome than motor fluctuations, improve with STN DBS. Although it is clear that NMSs are not target symptoms for STN DBS, NMSs have a strong influence on the quality of life of patients with PD, and clinicians should thus be aware of these NMSs when deciding whether to perform surgery and should pay attention to changes in these symptoms after STN DBS to ensure the optimal care for patients.

Citations

Citations to this article as recorded by  
  • A Wellness Prescription for Parkinson's: Mid to Late-stage Disease
    Gregory M Pontone, Bradley McDaniels, Adrienne M Keener, Indu Subramanian
    The American Journal of Geriatric Psychiatry.2023;[Epub]     CrossRef
  • Impact of deep brain stimulation (DBS) on olfaction in Parkinson's disease: Clinical features and functional hypotheses
    G. Brand, C. Bontempi, L. Jacquot
    Revue Neurologique.2023; 179(9): 947.     CrossRef
  • Time-locked acute alpha-frequency stimulation of subthalamic nuclei during the evaluation of emotional stimuli and its effect on power modulation
    Naeem Muhammad, Saurabh Sonkusare, Qiong Ding, Linbin Wang, Alekhya Mandali, Yi Jie Zhao, Bomin Sun, Dianyou Li, Valerie Voon
    Frontiers in Human Neuroscience.2023;[Epub]     CrossRef
  • Nutraceuticals a Food for Thought in the Treatment of Parkinson’s Disease
    Keshav Bansal, Sakshi Singh, Vanshita Singh, Meenakshi Bajpai
    Current Nutrition & Food Science.2023; 19(9): 961.     CrossRef
  • Subthalamic Nucleus Stimulation in Parkinson's Disease: 5‐Year Extension Study of a Randomized Trial
    Silje Bjerknes, Mathias Toft, Reidun Brandt, Trine Waage Rygvold, Ane Konglund, Espen Dietrichs, Stein Andersson, Inger Marie Skogseid
    Movement Disorders Clinical Practice.2022; 9(1): 48.     CrossRef
  • Effects of subthalamic deep brain stimulation on non‐motor symptoms of Parkinson's disease: A meta‐analysis
    Zahra Eghlidos, Zahra Rahimian, Gholamreza Vadiee, Soodeh Jahangiri
    Acta Neurologica Scandinavica.2022; 146(2): 115.     CrossRef
  • Nomogram for Predicting Depression Improvement after Deep Brain Stimulation for Parkinson’s Disease
    Bowen Chang, Chen Ni, Jiaming Mei, Chi Xiong, Peng Chen, Manli Jiang, Chaoshi Niu
    Brain Sciences.2022; 12(7): 841.     CrossRef
  • A nigra–subthalamic circuit is involved in acute and chronic pain states
    Cui Yin, Tao Jia, Yiwen Luan, Xue Zhang, Cheng Xiao, Chunyi Zhou
    Pain.2022; 163(10): 1952.     CrossRef
  • A nigro–subthalamo–parabrachial pathway modulates pain-like behaviors
    Tao Jia, Ying-Di Wang, Jing Chen, Xue Zhang, Jun-Li Cao, Cheng Xiao, Chunyi Zhou
    Nature Communications.2022;[Epub]     CrossRef
  • Basal impulses: findings from the last twenty years on impulsivity and reward pathways using deep brain stimulation
    Pavan S. UPADHYAYULA, Robert C. RENNERT, Joel R. MARTIN, John K. YUE, Jason YANG, Eva M. GILLIS-BUCK, Nikki SIDHU, Christopher K. CHEUNG, Anthony T. LEE, Reid R. HOSHIDE, Joseph D. CIACCI
    Journal of Neurosurgical Sciences.2021;[Epub]     CrossRef
  • Pallidal versus subthalamic deep-brain stimulation for meige syndrome: a retrospective study
    Jiayu Liu, Hu Ding, Ke Xu, Ruen Liu, Dongliang Wang, Jia Ouyang, Zhi Liu, Zeyu Miao
    Scientific Reports.2021;[Epub]     CrossRef
  • Eight‐year follow‐up outcome of subthalamic deep brain stimulation for Parkinson’s disease: Maintenance of therapeutic efficacy with a relatively low levodopa dosage and stimulation intensity
    Lulu Jiang, Wanru Chen, Qiyu Guo, Chao Yang, Jing Gu, Wenbiao Xian, Yanmei Liu, Yifan Zheng, Jing Ye, Shaohua Xu, Yu Hu, Lei Wu, Jie Chen, Hao Qian, Xiaoli Fu, Jinlong Liu, Ling Chen
    CNS Neuroscience & Therapeutics.2021; 27(11): 1366.     CrossRef
  • Clinical Impact of Deep Brain Stimulation on the Autonomic System in Patients with Parkinson's Disease
    Gabriele Bellini, Laura A. Best, Una Brechany, Russell Mills, Nicola Pavese
    Movement Disorders Clinical Practice.2020; 7(4): 373.     CrossRef
  • Reversal of hyperactive subthalamic circuits differentially mitigates pain hypersensitivity phenotypes in parkinsonian mice
    Yiwen Luan, Dongliang Tang, Haichuan Wu, Weixin Gu, Yuqing Wu, Jun-Li Cao, Cheng Xiao, Chunyi Zhou
    Proceedings of the National Academy of Sciences.2020; 117(18): 10045.     CrossRef
  • Impulsivity and Compulsivity After Subthalamic Deep Brain Stimulation for Parkinson’s Disease
    Sara Scherrer, Andrew H. Smith, Jaimie Gowatsky, Christina A. Palmese, Joohi Jimenez-Shahed, Brian H. Kopell, Helen S. Mayberg, Martijn Figee
    Frontiers in Behavioral Neuroscience.2020;[Epub]     CrossRef
  • Deep brain stimulation and recordings: Insights into the contributions of subthalamic nucleus in cognition
    Neil M. Drummond, Robert Chen
    NeuroImage.2020; 222: 117300.     CrossRef
  • Bilateral Subthalamic Nucleus Deep Brain Stimulation under General Anesthesia: Literature Review and Single Center Experience
    Hye Ran Park, Yong Hoon Lim, Eun Jin Song, Jae Meen Lee, Kawngwoo Park, Kwang Hyon Park, Woong-Woo Lee, Han-Joon Kim, Beomseok Jeon, Sun Ha Paek
    Journal of Clinical Medicine.2020; 9(9): 3044.     CrossRef
  • Subthalamic deep brain stimulation improves sleep and excessive sweating in Parkinson’s disease
    Silje Bjerknes, Inger Marie Skogseid, Tuva Jin Hauge, Espen Dietrichs, Mathias Toft
    npj Parkinson's Disease.2020;[Epub]     CrossRef
  • Impacto de la estimulación subtalámica a largo plazo sobre la situación cognitiva de los pacientes con enfermedad de Parkinson avanzada
    M. Acera, A. Molano, B. Tijero, G. Bilbao, I. Lambarri, R. Villoria, J. Somme, E. Ruiz de Gopegui, I. Gabilondo, J.C. Gomez-Esteban
    Neurología.2019; 34(9): 573.     CrossRef
  • The Subthalamic Nucleus: Unravelling New Roles and Mechanisms in the Control of Action
    Tora Bonnevie, Kareem A. Zaghloul
    The Neuroscientist.2019; 25(1): 48.     CrossRef
  • Modulation of specific components of sleep disturbances by simultaneous subthalamic and nigral stimulation in Parkinson's disease
    U. Hidding, A. Gulberti, C. Pflug, C. Choe, A. Horn, L. Prilop, H. Braaß, O. Fründt, C. Buhmann, D. Weiss, M. Westphal, A.K. Engel, C. Gerloff, J.A. Köppen, W. Hamel, C.K.E. Moll, M. Pötter-Nerger
    Parkinsonism & Related Disorders.2019; 62: 141.     CrossRef
  • Zona incerta GABAergic neurons integrate prey-related sensory signals and induce an appetitive drive to promote hunting
    Zheng-dong Zhao, Zongming Chen, Xinkuan Xiang, Mengna Hu, Hengchang Xie, Xiaoning Jia, Fang Cai, Yuting Cui, Zijun Chen, Lechen Qian, Jiashu Liu, Congping Shang, Yiqing Yang, Xinyan Ni, Wenzhi Sun, Ji Hu, Peng Cao, Haohong Li, Wei L. Shen
    Nature Neuroscience.2019; 22(6): 921.     CrossRef
  • Long-term impact of subthalamic stimulation on cognitive function in patients with advanced Parkinson's disease
    M. Acera, A. Molano, B. Tijero, G. Bilbao, I. Lambarri, R. Villoria, J. Somme, E. Ruiz de Gopegui, I. Gabilondo, J.C. Gomez-Esteban
    Neurología (English Edition).2019; 34(9): 573.     CrossRef
  • Influencia de la estimulación cerebral profunda en la carga de cuidadores de pacientes con enfermedad de Parkinson
    J.A. Crespo-Burillo, D. Rivero-Celada, A. Saenz-de Cabezón, J. Casado-Pellejero, J. Alberdi-Viñas, R. Alarcia-Alejos
    Neurología.2018; 33(3): 154.     CrossRef
  • Alteration in the Local and Global Functional Connectivity of Resting State Networks in Parkinson’s Disease
    Maryam Ghahremani, Jaejun Yoo, Sun Ju Chung, Kwangsun Yoo, Jong C. Ye, Yong Jeong
    Journal of Movement Disorders.2018; 11(1): 13.     CrossRef
  • Deep brain stimulation for patients with Parkinson's disease: Effect on caregiver burden
    J.A. Crespo-Burillo, D. Rivero-Celada, A. Saenz-de Cabezón, J. Casado-Pellejero, J. Alberdi-Viñas, R. Alarcia-Alejos
    Neurología (English Edition).2018; 33(3): 154.     CrossRef
  • Clinical Markers of Anxiety Subtypes in Parkinson Disease
    Martinus P. G. Broen, A. F. G. Leentjens, J. T. Hinkle, A. J. H. Moonen, M. L. Kuijf, N. M. Fischer, K. Perepezko, A. Bakker, G. M. Pontone
    Journal of Geriatric Psychiatry and Neurology.2018; 31(2): 55.     CrossRef
  • Apathy following Bilateral Deep Brain Stimulation of Subthalamic Nucleus in Parkinson’s Disease: A Meta-Analysis
    Ying Wang, Yongsheng Li, Xiaona Zhang, Anmu Xie
    Parkinson's Disease.2018; 2018: 1.     CrossRef
  • Non-motor Characterization of the Basal Ganglia: Evidence From Human and Non-human Primate Electrophysiology
    Robert S. Eisinger, Morgan E. Urdaneta, Kelly D. Foote, Michael S. Okun, Aysegul Gunduz
    Frontiers in Neuroscience.2018;[Epub]     CrossRef
  • Revealing a novel nociceptive network that links the subthalamic nucleus to pain processing
    Arnaud Pautrat, Marta Rolland, Margaux Barthelemy, Christelle Baunez, Valérie Sinniger, Brigitte Piallat, Marc Savasta, Paul G Overton, Olivier David, Veronique Coizet
    eLife.2018;[Epub]     CrossRef
  • Cerebrospinal fluid protein markers in PD patients after DBS-STN surgery—A retrospective analysis of patients that underwent surgery between 1993 and 2001
    Radu Constantinescu, Kaj Blennow, Lars Rosengren, Barbro Eriksson, Thordis Gudmundsdottir, Yvonne Jansson, Bo Johnels, Annika Renck, Filip Bergquist
    Clinical Neurology and Neurosurgery.2018; 174: 174.     CrossRef
  • Predictors to quality of life improvements after subthalamic stimulation in Parkinson’s disease
    Feng‐Tao Liu, Li‐Qin Lang, Yu‐Jie Yang, Jue Zhao, Rui Feng, Jie Hu, Jian Wang, Jian‐Jun Wu
    Acta Neurologica Scandinavica.2018;[Epub]     CrossRef
  • Apathy associated with neurocognitive disorders: Recent progress and future directions
    Krista L. Lanctôt, Luis Agüera‐Ortiz, Henry Brodaty, Paul T. Francis, Yonas E. Geda, Zahinoor Ismail, Gad A. Marshall, Moyra E. Mortby, Chiadi U. Onyike, Prasad R. Padala, Antonios M. Politis, Paul B. Rosenberg, Emma Siegel, David L. Sultzer, Eleenor H. A
    Alzheimer's & Dementia.2017; 13(1): 84.     CrossRef
  • Can deep brain stimulation be a therapeutic option for Parkinson's disease dementia?
    Han‐Joon Kim, Beomseok Jeon, Jee‐Young Lee, Sun Ha Paek
    Neurology and Clinical Neuroscience.2017; 5(1): 3.     CrossRef
  • The effect of deep brain stimulation on the non-motor symptoms of Parkinson’s disease: a critical review of the current evidence
    Mónica M Kurtis, Thadshani Rajah, Luisa F Delgado, Haidar S Dafsari
    npj Parkinson's Disease.2017;[Epub]     CrossRef
  • Delayed responses of subthalamic nucleus to deep brain stimulation in patients with Parkinson's disease
    Lin Shi, Kai Zhang, Fan-Gang Meng, Guan-Yu Zhu, Ying-Chuan Chen, Jun-Jian Zhou, Zhong-Hai Zhou, Jian-Guo Zhang
    Parkinsonism & Related Disorders.2017; 40: 76.     CrossRef
  • Acute response of non-motor symptoms to subthalamic deep brain stimulation in Parkinson's disease
    Margherita Fabbri, Miguel Coelho, Leonor Correia Guedes, Mario M. Rosa, Daisy Abreu, Nilza Gonçalves, Angelo Antonini, Joaquim J. Ferreira
    Parkinsonism & Related Disorders.2017;[Epub]     CrossRef
  • Deep Brain Stimulation of Hemiparkinsonian Rats with Unipolar and Bipolar Electrodes for up to 6 Weeks: Behavioral Testing of Freely Moving Animals
    Kathrin Badstuebner, Ulrike Gimsa, Immo Weber, Armin Tuchscherer, Jan Gimsa
    Parkinson's Disease.2017; 2017: 1.     CrossRef
  • Current Topics in Deep Brain Stimulation for Parkinson Disease
    Atsushi UMEMURA, Genko OYAMA, Yasushi SHIMO, Madoka NAKAJIMA, Asuka NAKAJIMA, Takayuki JO, Satoko SEKIMOTO, Masanobu ITO, Takumi MITSUHASHI, Nobutaka HATTORI, Hajime ARAI
    Neurologia medico-chirurgica.2016; 56(10): 613.     CrossRef
  • In Parkinson’s disease STN stimulation enhances responsiveness of movement initiation speed to high reward value
    Maja Kojovic, Andrea Higgins, Marjan Jahanshahi
    Neuropsychologia.2016; 89: 273.     CrossRef
  • Restoring Spinal Noradrenergic Inhibitory Tone Attenuates Pain Hypersensitivity in a Rat Model of Parkinson’s Disease
    Lei-Fang Cao, Xiao-Yan Peng, Ya Huang, Bing Wang, Feng-Ming Zhou, Ruo-Xiao Cheng, Li-Hua Chen, Wei-Feng Luo, Tong Liu
    Neural Plasticity.2016; 2016: 1.     CrossRef
  • The KMDS-NATION Study: Korean Movement Disorders Society Multicenter Assessment of Non-Motor Symptoms and Quality of Life in Parkinson's Disease NATION Study Group
    Do-Young Kwon, Seong-Beom Koh, Jae Hyeok Lee, Hee Kyung Park, Han-Joon Kim, Hae-Won Shin, Jinyoung Youn, Kun Woo Park, Sun-Ah Choi, Sang Jin Kim, Seong-Min Choi, Ji-Yun Park, Beom S. Jeon, Ji Young Kim, Sun Ju Chung, Chong Sik Lee, Jeong-Ho Park, Tae-Beom
    Journal of Clinical Neurology.2016; 12(4): 393.     CrossRef
  • Antiparkinsonian Treatment for Depression in Parkinson's Disease: Are Selective Serotonin Reuptake Inhibitors Recommended?
    Philippe De Deurwaerdère, Yuqiang Ding
    Translational Neuroscience and Clinics.2016; 2(2): 138.     CrossRef
  • The Subthalamic Nucleus, Limbic Function, and Impulse Control
    P. Justin Rossi, Aysegul Gunduz, Michael S. Okun
    Neuropsychology Review.2015; 25(4): 398.     CrossRef

JMD : Journal of Movement Disorders